Stocks
Immunome (IMNM) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -51.3% | -221.6% | -89.1% | -161.7% | -33.5% | -38.2% | ||
| Changes by years, y/y, % | -8pp | -170pp | +132pp | -73pp | +128pp | -4.9% | |||
Immunome. ROE, %
Immunome. ROE, changes, pp
Immunome (IMNM) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -66.8% | -78.9% | -84.4% | -33.5% | -38.2% | -38.2% | |
| Changes by years, y/y, % | +14pp | +25pp | +58pp | +128pp | +29pp | |||
| Changes by quarters, q/q, % | +95pp | -12pp | -6pp | +51pp | -5pp | |||
